These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11827300)

  • 1. Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe.
    Marufu T; Siziya S
    J Trop Pediatr; 2001 Dec; 47(6):335-8. PubMed ID: 11827300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of protection afforded by single measles vaccination and late revaccination schedules.
    Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E
    East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing age ecology of measles and its implications on measles control.
    Marufu T
    Cent Afr J Med; 1992 Jun; 38(6):208-14. PubMed ID: 1394401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questioning the level of efficacy of the measles vaccine in use in Zimbabwe.
    Marufu T; Siziya S; Manyame B; Xaba E; Silape-Marufu Z; Zimbizi P; Ruwodo C; Mason E; Matchaba-Hove RB; Mudyarabikwa O
    Cent Afr J Med; 1995 Aug; 41(8):241-5. PubMed ID: 7585910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001.
    Munyoro MN; Kufa E; Biellik R; Pazvakavambwa IE; Cairns KL
    J Infect Dis; 2003 May; 187 Suppl 1():S91-6. PubMed ID: 12721898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles control in a rural area in Zimbabwe.
    Tumwine JK
    East Afr Med J; 1991 Sep; 68(9):694-701. PubMed ID: 1797531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measles control in developing countries].
    Cutts FT; Dabis F
    Sante; 1994; 4(3):163-71. PubMed ID: 7921681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the protection afforded measles vaccinees the same in children of all age groups?
    Marufu T; Murugasampillary S; Siziya S; Manyame B; Silape-Marufu Z; Xaba E; Zimbizi P; Ruwodo C; Mudyarabikwa O; Matchaba-Hove R
    Cent Afr J Med; 1995 May; 41(5):144-7. PubMed ID: 7627998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges posed by changes in measles transmission patterns.
    Marufu T; Siziya S; Tshimanga M; Xaba E; Ruwodo C; Silape Z; Baye T; Hhlazo M
    Cent Afr J Med; 1998 Jan; 44(1):5-8. PubMed ID: 9631106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles immunization: early two-doses policy experience.
    al-Mazrou YY; al-Jeffri M; Ahmed OM; Aziz KM; Mishkas AH
    J Trop Pediatr; 1999 Apr; 45(2):98-104. PubMed ID: 10341504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles vaccination before nine months.
    George K; Joseph A; Muliyil J; Abraham S; Bhattacharji S; John KR
    Trop Med Int Health; 1998 Sep; 3(9):751-6. PubMed ID: 9754672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy.
    Gay NJ; Pelletier L; Duclos P
    Vaccine; 1998 May; 16(8):794-801. PubMed ID: 9627936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995.
    Kaninda AV; Legros D; Jataou IM; Malfait P; Maisonneuve M; Paquet C; Moren A
    Pediatr Infect Dis J; 1998 Nov; 17(11):1034-9. PubMed ID: 9849988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.